NeuPath Health Inc (NPTH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NeuPath Health Inc (NPTH) has a cash flow conversion efficiency ratio of -0.010x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-203.00K ≈ $-146.85K USD) by net assets (CA$21.32 Million ≈ $15.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NeuPath Health Inc (NPTH) balance sheet quality index to measure how much of total assets are equity-financed.
NeuPath Health Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how NeuPath Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NPTH cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
NeuPath Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NeuPath Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
QPM Energy Ltd
AU:QPM
|
-0.108x |
|
N.D. Rubber Public Company Limited
BK:NDR
|
0.014x |
|
Atech OEM
TWO:6109
|
-0.036x |
|
Talam Transform Bhd
KLSE:2259
|
-0.018x |
|
Generic Engineering Construction and Projects Limited
NSE:GENCON
|
0.063x |
|
Sewoo Global Co., Ltd
KO:013000
|
0.028x |
|
Seoam Machinery Industry Co.Ltd
KQ:100660
|
-0.021x |
|
GWR Group Ltd
AU:GWR
|
0.020x |
Annual Cash Flow Conversion Efficiency for NeuPath Health Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of NeuPath Health Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see how much is NeuPath Health Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$20.95 Million ≈ $15.16 Million |
CA$4.00 Million ≈ $2.90 Million |
0.191x | +57.07% |
| 2024-12-31 | CA$21.43 Million ≈ $15.50 Million |
CA$2.61 Million ≈ $1.89 Million |
0.122x | -12.33% |
| 2023-12-31 | CA$21.84 Million ≈ $15.80 Million |
CA$3.03 Million ≈ $2.19 Million |
0.139x | +307.07% |
| 2022-12-31 | CA$21.65 Million ≈ $15.66 Million |
CA$738.00K ≈ $533.86K |
0.034x | -54.12% |
| 2021-12-31 | CA$25.83 Million ≈ $18.69 Million |
CA$1.92 Million ≈ $1.39 Million |
0.074x | +417.69% |
| 2020-12-31 | CA$27.62 Million ≈ $19.98 Million |
CA$-646.00K ≈ $-467.31K |
-0.023x | +76.83% |
| 2019-12-31 | CA$9.77 Million ≈ $7.07 Million |
CA$-986.00K ≈ $-713.26K |
-0.101x | -- |
About NeuPath Health Inc
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and di… Read more